Features
Our editorial board comprises a specialist group of leading industry figures who, in conjunction with the pharmaceutical technology editorial team, identify the main drivers of the industry helping to produce regular, thought provoking opinion pieces on the latest issues, challenges and developments.Latest Pharmaceutical Feature
It's well known that overusing antibiotics can lead to resistance, but what of the altogether more surreptitious variety entering our bodies via the food we eat? Dr Nicola Davies reports on...
> read more
By Category
April's top stories: Roche discloses Tamiflu data, Novartis patent rejected in India Roche finally reveals its full Tamiflu data to researchers after a three year delay, Norvartis loses cancer patent bid in landmark ruling in India, and $100m brain research project launched in...
Newcastle disease: the cancer-killing avian virus Despite the fear surrounding animal-borne disease outbreaks, the study of animal viruses is yielding promising clinical results. The most recent breakthrough in this field has been made by...
Pharma Technology Focus - Issue 22 In this issue we explore the measures being taken to stop cheap drugs being resold for higher prices outside of Europe, GSK’s pledge to be more transparent, how the future of painkiller...
Noble intentions – the EU's Falsified Medicines Directive The commencement of the European Commission's Falsified Medicines Directive (FMD) in January 2013 marks that latest step in the bid to rid Europe of dangerous medicines. Dr Nicola Davies finds...
March's top stories: child cured of HIV and AstraZeneca axes nearly 3,000 jobs US doctors declared a breakthrough in the fight against aids by curing a baby of HIV, while French scientists said the infection could be 'functionally cured' with early treatment,...
Pharma tackles the patent cliff Prompted by expiring patents and a shrinking product pipeline, pharmaceutical companies underwent mergers and acquisitions to make up for the drop in revenues in 2012. Adefemi Adenuga,...
Mexico: growing South America's pharmaceutical industry An improving regulatory environment and high foreign investment has made Mexico's pharmaceutical market one to watch. Worth $13.47bn (£8.87bn) in 2012, only Brazil's is bigger in South...
The outdoor lab: growing pharmaceuticals in plants Growing medicines in open fields could slash the cost of drug production and make life-saving vaccines easily available to people in the developing world. But current regulations mean it...
Pharma Technology Focus - Issue 21 Issue 21: In this issue we explore the idea of using crowdfunding to develop new treatments, look at the clinical trial of the first HIV vaccine and investigate progress in inhalation...
February's top stories: Takeda anemia drug pulled, EU investigates Diane 35 The EU launches a review of acne drug Diane 35, Takeda pulls anemia drug Omontys in the US over fatal hypersensitivity and scientists prepare to explore the Arctic seabed for new...
Twitter
Facebook